[The serum copper/serum iron ratio in malignant tumors of the female genitalia].
Copper and iron in blood of 83 women with maligne tumors of the genitalia were regulary controled before, during and till 69 weeks after therapy. The relation between the copper/iron-ratio and the expansion and histology of the tumors, the success of the therapy and the incidence of a recurrence was checked for any significancy. Our results show the improtance of the ratio in the diagnosis and differentialdiagnosis of the ovarian-cancer and the corpus-uteri-cancer, and in the success-controll during tumor-therapy. In the group of the patients with collum-uteri-cancer we found a significant difference in the copper/iron-ratio of the patients with and without a recurrence during the controllperiod after therapy, which emphasizes the importance of this copper/iron-ratio.
D000328:Adult; D000368:Aged; D003300:Copper / Q000097:blood*; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D005831:Genital Diseases, Female / Q000097:blood / Q000175:diagnosis; D005833:Genital Neoplasms, Female / Q000097:blood*; D006801:Humans; D007501:Iron / Q000097:blood*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D012008:Recurrence; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D014594:Uterine Neoplasms / Q000097:blood / Q000175:diagnosis / Q000628:therapy
D003300:Copper; D007501:Iron
Der Serumkupfer/Serumeisen-Qotient bei maligen Tumoren des weiblichen Genitale